NGNE logo

NGNE

Neurogene Inc.NASDAQHealthcare
$20.69-1.06%ClosedMarket Cap: $322.2M

As of 2026-04-06

Insider Statistics (Q2 2025)

Purchases

5

Sales

1

Buy/Sell Ratio

5.00

Total Bought

$0.00

Total Sold

$1.00

Recent Insider Trades
Filing DateNameTypeActionSharesPriceShares After
Mon Mar 30Jordan Julieofficer: Chief Medical OfficerSell828$21.8912,472
Mon Mar 30McMinn Racheldirector, officer: Chief Executive OfficerSell3,352$22.071,344,307
Mon Mar 30Cvijic Christine Mikailofficer: President and CFOSell2,558$21.62103,240
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell2,387$20.42107,456
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell1,395$21.25106,061
Tue Mar 17Cvijic Christine Mikailofficer: President and CFOSell263$22.02105,798
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell3,991$20.4133,303
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell2,658$21.3430,645
Tue Mar 17Cobb Stuartofficer: Chief Scientific OfficerSell148$22.0830,497
Tue Mar 03Cvijic Christine Mikailofficer: President and CFOSell4,800$25.11109,843
Tue Feb 24Jordan Julieofficer: Chief Medical OfficerSell4,900$0.0013,300
Tue Feb 24Jordan Julieofficer: Chief Medical OfficerSell29,600$17.6429,600
Tue Feb 24Cobb Stuartofficer: Chief Scientific OfficerSell16,500$0.0037,294